Compounded vs Brand-Name GLP-1: Which Should You Choose?

The choice between compounded and brand-name GLP-1 is really a choice about what you are willing to trade. Brand-name buys you an FDA-approved, quality-controlled product. Compounded buys you access and a lower price. Neither is universally "better" — but the marketing on both sides is loud enough that it helps to see the trade plainly.

What "brand-name" actually means

Brand-name GLP-1s — Wegovy (semaglutide) and Zepbound (tirzepatide) for weight management — are FDA-approved finished drugs. That approval means the FDA has reviewed the manufacturer's evidence for safety and effectiveness and holds every batch to a defined manufacturing standard. Wegovy is approved for chronic weight management at a 2.4 mg weekly maintenance dose¹; Zepbound is approved for chronic weight management across its 5, 10, and 15 mg doses². The efficacy behind those approvals is real: semaglutide produced roughly 15% mean weight loss in STEP-1³, and tirzepatide about 21% at its top dose in SURMOUNT-1⁴.

What "compounded" actually means

Compounded semaglutide and tirzepatide are prepared by pharmacies rather than the original manufacturer. The critical fact: compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality the way it does for brand-name products⁵. They exist in a specific regulatory lane — 503A pharmacies compounding for an individual patient, or 503B outsourcing facilities that are FDA-registered and held to tighter standards⁵. Compounded versions use the same underlying molecules, but the finished-product oversight is fundamentally different, and quality depends on the specific pharmacy.

The honest trade-off

Choose **brand-name** if: you want FDA-approved certainty, your insurance meaningfully offsets the cost, or you simply will not accept a non-approved product. The cost is the sticker — brand-name typically runs well above compounded when paid out of pocket.

Choose **compounded** if: out-of-pocket affordability is decisive, you want faster access, and you are willing to vet the pharmacy carefully. Compounded programs on our board disclose flat monthly pricing that undercuts brand-name substantially — see what compounded GLP-1 costs per month. The catch is that verification becomes your job; we cover how to do it in is compounded semaglutide legit and safe.

A few myths to retire

"Compounded is fake." It is not fake — it uses the real molecules — but it is not FDA-approved, and that distinction is the whole point.

"Brand-name is always safer." Brand-name is FDA-approved and batch-consistent, which is a genuine advantage. But a compounded prescription from a well-run, verified pharmacy is a different proposition from an unverified one; the pharmacy matters more than the label.

"They work differently." The molecules are the same. If a provider offers you a "GLP-1 alternative" that is neither semaglutide nor tirzepatide, that is a separate — and usually worse — decision.

How we factor it into scores

On our board, brand-name access is a formulary-choice advantage, not an automatic winner. A provider that offers both compounded and brand-name (and can pivot if compounded supply tightens) scores higher on optionality. But a provider is not penalized for being compounded-only if it is honestly priced and verified. The full weighting is in our Verdict Score methodology, and you can compare providers head to head in the reviews.